<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30038419</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>01</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">2045-2322</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>8</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Jul</Month>                        <Day>23</Day>                    </PubDate>                </JournalIssue>                <Title>Scientific reports</Title>                <ISOAbbreviation>Sci Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>Mapping the genetic basis of breast microcalcifications and their role in metastasis.</ArticleTitle>            <Pagination>                <MedlinePgn>11067</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-29330-9</ELocationID>            <Abstract>                <AbstractText>Breast cancer screening and early stage diagnosis is typically performed by X-ray mammography, which detects microcalcifications. Despite being one of the most reliable features of nonpalpable breast cancer, the processes by which these microcalcifications form are understudied and largely unknown. In the current work, we have investigated the genetic drivers for the formation of microcalcifications in breast cancer cell lines, and have investigated their involvement in disease progression. We have shown that stable silencing of the Osteopontin (OPN) gene decreased the formation of hydroxyapatite in MDA-MB-231 breast cancer cells in response to osteogenic cocktail. In addition, OPN silencing reduced breast cancer cell migration. Furthermore, breast cancer cells that had spontaneously metastasized to the lungs in a mouse model of breast cancer had largely elevated OPN levels, while circulating tumor cells in the same mouse model contained intermediately increased OPN levels as compared to parental cells. The observed dual roles of the OPN gene reveal the existence of a direct relationship between calcium deposition and the ability of breast cancer cells to metastasize to distant organs, mediated by common genetic factors.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Rizwan</LastName>                    <ForeName>Asif</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>The Johns Hopkins University In Vivo Cellular and Molecular Imaging Center, Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Paidi</LastName>                    <ForeName>Santosh Kumar</ForeName>                    <Initials>SK</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7034-586X</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Mechanical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zheng</LastName>                    <ForeName>Chao</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mechanical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cheng</LastName>                    <ForeName>Menglin</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>The Johns Hopkins University In Vivo Cellular and Molecular Imaging Center, Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Barman</LastName>                    <ForeName>Ishan</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mechanical Engineering, Johns Hopkins University, Baltimore, Maryland, USA. ibarman@jhu.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA. ibarman@jhu.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Glunde</LastName>                    <ForeName>Kristine</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>The Johns Hopkins University In Vivo Cellular and Molecular Imaging Center, Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. kglunde@mri.jhu.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA. kglunde@mri.jhu.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA. kglunde@mri.jhu.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>R01CA213428</GrantID>                    <Agency>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute (NCI)</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>R01 CA213492</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>DP2 GM128198</GrantID>                    <Acronym>GM</Acronym>                    <Agency>NIGMS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01CA154725</GrantID>                    <Agency>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute (NCI)</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>P41 EB015871</GrantID>                    <Acronym>EB</Acronym>                    <Agency>NIBIB NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01 CA154725</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01 CA213428</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>23</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Sci Rep</MedlineTA>            <NlmUniqueID>101563288</NlmUniqueID>            <ISSNLinking>2045-2322</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Biochim Biophys Acta. 1989 Jun 13;996(1-2):43-8</RefSource>                <PMID Version="1">2736258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 May 07;5:10002</RefSource>                <PMID Version="1">25950608</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2018 Mar;109(3):710-723</RefSource>                <PMID Version="1">29285854</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2010 Oct 28;296(2):216-24</RefSource>                <PMID Version="1">20452118</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 May;121(1):53-64</RefSource>                <PMID Version="1">19593635</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2018 Jan;68(1):7-30</RefSource>                <PMID Version="1">29313949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Ther Targets. 2014 Aug;18(8):883-95</RefSource>                <PMID Version="1">24899149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 1994 Aug;9(8):2321-6</RefSource>                <PMID Version="1">8036014</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1999 Jan 1;59(1):219-26</RefSource>                <PMID Version="1">9892210</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2014 Sep;14(9):623-31</RefSource>                <PMID Version="1">25154812</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Surg. 1999 Jul;134(7):712-5; discussion 715-6</RefSource>                <PMID Version="1">10401820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1996 Jan 26;271(5248):509-12</RefSource>                <PMID Version="1">8560266</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lab Invest. 2005 Jan;85(1):154-9</RefSource>                <PMID Version="1">15543203</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FASEB J. 2010 Jun;24(6):1838-51</RefSource>                <PMID Version="1">20097873</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2005 Aug 1;65(15):6755-63</RefSource>                <PMID Version="1">16061657</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52</RefSource>                <PMID Version="1">25352553</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1994 Feb 1;54(3):832-7</RefSource>                <PMID Version="1">8306346</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Radiol. 2003 Sep;47(3):227-31</RefSource>                <PMID Version="1">12927667</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2012 Jan 31;106(3):525-37</RefSource>                <PMID Version="1">22233923</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Protoc. 2008;3(6):1101-8</RefSource>                <PMID Version="1">18546601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2013 Sep 15;19(18):5158-69</RefSource>                <PMID Version="1">23833310</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):181-7</RefSource>                <PMID Version="1">16025224</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2014 Apr 23;14:286</RefSource>                <PMID Version="1">24758513</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Methods. 2012 Jul;9(7):671-5</RefSource>                <PMID Version="1">22930834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 1997 Apr;3(4):605-11</RefSource>                <PMID Version="1">9815727</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Feb;138(1):81-90</RefSource>                <PMID Version="1">23412770</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1087-97</RefSource>                <PMID Version="1">17548669</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Dial. 2007 Mar-Apr;20(2):103-9</RefSource>                <PMID Version="1">17374082</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1994 Jun 1;54(11):2823-6</RefSource>                <PMID Version="1">8187059</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biochem. 2007 Nov 1;102(4):859-68</RefSource>                <PMID Version="1">17721886</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2016 Sep 12;30(3):432-443</RefSource>                <PMID Version="1">27593345</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2006 Dec;10(6):515-27</RefSource>                <PMID Version="1">17157791</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Connect Tissue Res. 1996;35(1-4):197-205</RefSource>                <PMID Version="1">9084658</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 1995 Jan;146(1):95-100</RefSource>                <PMID Version="1">7856741</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Physiol Biochem. 2014;33(4):991-1002</RefSource>                <PMID Version="1">24714122</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Calcif Tissue Int. 2005 Jul;77(1):45-54</RefSource>                <PMID Version="1">16007483</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):333-45</RefSource>                <PMID Version="1">18952487</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Surg. 2013 Jul;217(1):17-26; discussion 26</RefSource>                <PMID Version="1">23619316</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bone Miner. 1993 Aug;22(2):147-59</RefSource>                <PMID Version="1">8251766</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Apr 30;5:9907</RefSource>                <PMID Version="1">25927331</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Opin Rheumatol. 2006 Mar;18(2):174-80</RefSource>                <PMID Version="1">16462525</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2011 Apr;11(4):254-67</RefSource>                <PMID Version="1">21390059</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>NPJ Breast Cancer. 2015 Oct 28;1:15017</RefSource>                <PMID Version="1">28721370</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Radiol. 1999 Oct;54(10):644-6</RefSource>                <PMID Version="1">10541387</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2016 Jun 10;16:359</RefSource>                <PMID Version="1">27282619</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 1979 Apr;16(4):885-93</RefSource>                <PMID Version="1">88265</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>08</Month>                <Day>31</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30038419</ArticleId>            <ArticleId IdType="doi">10.1038/s41598-018-29330-9</ArticleId>            <ArticleId IdType="pii">10.1038/s41598-018-29330-9</ArticleId>            <ArticleId IdType="pmc">PMC6056534</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>